Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Chronic Inflammatory Demyelinating Polyradiculoneuropathy

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

7 trials tracked for Chronic Inflammatory Demyelinating Polyradiculoneuropathy: 7 in phase 3 or 4 and 2 with published results. The most-cited published study has 73 citations.

7Trials tracked
7Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 3 7
  1. Phase 3 Evaluate Efficacy and Safety of Fingolimod 0.5 mg Orally Once Daily Versus Placebo in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients. Completed · 73 cited
  2. Phase 3 Study to Evaluate Safety and Efficacy of Three Different Dosages of NewGam in Patients With Chronic Inflammatory Demyelinating Poly (Radiculo) Neuropathy Completed · 40 cited
  3. Phase 3 Extension Study of Maintenance Treatment With Subcutaneous Immunoglobulin (IgPro20) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Completed
  4. Phase 3 Efficacy and Safety Study of I10E in Treatment of Patients With CIDP Completed
  5. Phase 3 A Study of HyQvia and Gammagard Liquid (Kiovig) in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Completed
  6. Phase 3 Long-Term Tolerability and Safety of HYQVIA/HyQvia in CIDP Completed
Show 1 more trials
  1. Phase 3 Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Completed

Showing the 7 most-cited and recently-updated of 7 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this condition. Check back soon.